The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...

Insider has named its second batch of choices for the most promising younger businesses in Yorkshire.

Trump also says he is using tariffs to "combat the scourge of fentanyl", a powerful drug that causes tens of thousands of ...

BP’s shares are on the up despite poor Q4 results, as shareholders look to activist investor Elliott Investment Management to ...

The moves are part of an aggressive push by the president to reset global trade, with Mr Trump saying that tax hikes on the people and companies buying foreign ... be coming on computer chips, autos ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in ...

Inc. has seen its shares tumble to a 52-week low, reaching a price level of just $0.31. According to InvestingPro data, the company's market capitalization has shrunk to just $1.96 million, with ...

A battle over how to treat childhood obesity is brewing between those in favour and others who warn of the effects on growing bodies ...

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ...